All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - COVID‐19
Using heparin molecules to manage COVID-2019
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
Fibrinolysis and COVID‐19: A plasmin paradox
Read more...
Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications
Read more...
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Read more...
Heparin - An old drug with multiple potential targets in Covid-19 therapy
Read more...
D-dimer Triage for COVID-19
Read more...
Dynamic relationship between D-dimer and COVID-19 severity
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Potential role of platelets in COVID-19: Implications for thrombosis
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Fibrinolysis and COVID-19: A tale of two sites?
Read more...
High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?
Read more...
Frequency of lupus anticoagulant in COVID-19 patients
Read more...
Macrothrombosis and stroke in patients with mild Covid‐19 infection
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
Read more...
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Read more...
A proposal for staging COVID-19 coagulopathy
Read more...
Understanding the COVID-19 coagulopathy spectrum
Read more...
COVID‐19: A collision of complement, coagulation and inflammatory pathways
Read more...
Response to "All these D-dimers in COVID-19"
Read more...
Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
Read more...
The contact activation system as a potential therapeutic target in patients with COVID‐19
Read more...
COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation
Read more...
Pulmonary embolism during the COVID-19 pandemic: Decline in diagnostic procedures and incidence at a university hospital
Read more...
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
Read more...
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection